tiprankstipranks
Compugen (CGEN)
NASDAQ:CGEN
US Market
CGEN
Compugen
RESEARCH TOOLSreports
Want to see CGEN full AI Analyst Report?

Compugen (CGEN) Stock Forecast & Price Target

1,060 Followers
See the Price Targets and Ratings of:

CGEN Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Compugen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CGEN Stock 12 Month Forecast

Average Price Target

$4.75
▲(68.44% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Compugen in the last 3 months. The average price target is $4.75 with a high forecast of $6.00 and a low forecast of $4.00. The average price target represents a 68.44% change from the last price of $2.82.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.963076923076923,3.216153846153846,3.4692307692307693,3.7223076923076923,3.9753846153846153,4.228461538461539,4.481538461538461,4.734615384615385,4.987692307692308,5.240769230769231,5.493846153846154,5.746923076923077,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.8669230769230767,3.023846153846154,3.1807692307692306,3.3376923076923077,3.4946153846153845,3.651538461538461,3.8084615384615383,3.9653846153846155,4.122307692307692,4.279230769230769,4.436153846153847,4.593076923076923,{"y":4.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.809230769230769,2.9084615384615384,3.0076923076923077,3.106923076923077,3.206153846153846,3.3053846153846154,3.4046153846153846,3.503846153846154,3.603076923076923,3.7023076923076923,3.8015384615384615,3.9007692307692308,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.43,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.77,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.53,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$6.00Average Price Target$4.75Lowest Price Target$4.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CGEN
Daina Graybosch
Leerink Partners
Leerink Partners
$13→$5
Buy
77.30%
Upside
Reiterated
05/21/26
Compugen price target lowered to $5 from $13 at LeerinkCompugen price target lowered to $5 from $13 at Leerink
H.C. Wainwright Analyst forecast on CGEN
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$4
Buy
41.84%
Upside
Reiterated
05/19/26
Compugen: Advancing Clinical Pipeline and AstraZeneca Partnership Underpin Buy Rating with Unchanged $4 Price Target
Lake Street Analyst forecast on CGEN
Chad Messer
Lake Street
Lake Street
$6
Buy
112.77%
Upside
Reiterated
05/19/26
Analysts' Top Healthcare Picks: Compugen (CGEN), TriSalus Life Sciences (TLSI)
Truist Financial Analyst forecast on CGEN
Asthika Goonewardene
Truist Financial
Truist Financial
$4
Buy
41.84%
Upside
Reiterated
03/03/26
Truist Financial Sticks to Its Buy Rating for Compugen (CGEN)
Oppenheimer Analyst forecast on CGEN
Leland Gershell
Oppenheimer
Oppenheimer
$4
Buy
41.84%
Upside
Reiterated
10/14/25
Analysts Offer Insights on Healthcare Companies: Compugen (NASDAQ: CGEN) and AbbVie (NYSE: ABBV)
Stifel Nicolaus Analyst forecast on CGEN
Unknown Analyst
Stifel Nicolaus
Not Ranked
Stifel Nicolaus
$1.39→$4
Buy
41.84%
Upside
Reiterated
05/26/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on CGEN
Daina Graybosch
Leerink Partners
Leerink Partners
$13→$5
Buy
77.30%
Upside
Reiterated
05/21/26
Compugen price target lowered to $5 from $13 at LeerinkCompugen price target lowered to $5 from $13 at Leerink
H.C. Wainwright Analyst forecast on CGEN
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$4
Buy
41.84%
Upside
Reiterated
05/19/26
Compugen: Advancing Clinical Pipeline and AstraZeneca Partnership Underpin Buy Rating with Unchanged $4 Price Target
Lake Street Analyst forecast on CGEN
Chad Messer
Lake Street
Lake Street
$6
Buy
112.77%
Upside
Reiterated
05/19/26
Analysts' Top Healthcare Picks: Compugen (CGEN), TriSalus Life Sciences (TLSI)
Truist Financial Analyst forecast on CGEN
Asthika Goonewardene
Truist Financial
Truist Financial
$4
Buy
41.84%
Upside
Reiterated
03/03/26
Truist Financial Sticks to Its Buy Rating for Compugen (CGEN)
Oppenheimer Analyst forecast on CGEN
Leland Gershell
Oppenheimer
Oppenheimer
$4
Buy
41.84%
Upside
Reiterated
10/14/25
Analysts Offer Insights on Healthcare Companies: Compugen (NASDAQ: CGEN) and AbbVie (NYSE: ABBV)
Stifel Nicolaus Analyst forecast on CGEN
Unknown Analyst
Stifel Nicolaus
Not Ranked
Stifel Nicolaus
$1.39→$4
Buy
41.84%
Upside
Reiterated
05/26/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Compugen

3 Months
Asthika GoonewardeneTruist Financial
Success Rate
8/18 ratings generated profit
44%
Average Return
+4.60%
Copying Asthika Goonewardene's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +4.60% per trade.
1 Year
Asthika GoonewardeneTruist Financial
Success Rate
8/18 ratings generated profit
44%
Average Return
+1.63%
Copying Asthika Goonewardene's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +1.63% per trade.
2 Years
Asthika GoonewardeneTruist Financial
Success Rate
10/18 ratings generated profit
56%
Average Return
+6.01%
Copying Asthika Goonewardene's trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +6.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGEN Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
2
1
3
3
5
Buy
0
0
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
1
3
3
6
In the current month, CGEN has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGEN average Analyst price target in the past 3 months is 4.75.
Each month's total comprises the sum of three months' worth of ratings.

CGEN Financial Forecast

CGEN Earnings Forecast

Next quarter’s earnings estimate for CGEN is -$0.08 with a range of -$0.10 to -$0.05. The previous quarter’s EPS was -$0.08. CGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CGEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for CGEN is -$0.08 with a range of -$0.10 to -$0.05. The previous quarter’s EPS was -$0.08. CGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CGEN has Performed in-line its overall industry.

CGEN Sales Forecast

Next quarter’s sales forecast for CGEN is $1.28M with a range of $0.00 to $2.52M. The previous quarter’s sales results were $2.18M. CGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CGEN has Performed in-line its overall industry.
Next quarter’s sales forecast for CGEN is $1.28M with a range of $0.00 to $2.52M. The previous quarter’s sales results were $2.18M. CGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CGEN has Performed in-line its overall industry.

CGEN Stock Forecast FAQ

What is CGEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Compugen’s 12-month average price target is 4.75.
    What is CGEN’s upside potential, based on the analysts’ average price target?
    Compugen has 68.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CGEN a Buy, Sell or Hold?
          Compugen has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Compugen’s price target?
            The average price target for Compugen is 4.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $6.00 ,the lowest forecast is $4.00. The average price target represents 68.44% Increase from the current price of $2.82.
              What do analysts say about Compugen?
              Compugen’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of CGEN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.